-
Something wrong with this record ?
Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease
O. Zakiyanov, M. Kalousová, T. Zima, V. Tesař
Language English Country United States
Document type Journal Article, Review
- MeSH
- Extracellular Matrix Proteins MeSH
- Humans MeSH
- Matrix Metalloproteinases metabolism MeSH
- Kidney Diseases * MeSH
- Signal Transduction MeSH
- Tissue Inhibitor of Metalloproteinases * metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Matrix metalloproteinases (MMPs) are a group of zinc and calcium endopeptidases which cleave extracellular matrix (ECM) proteins. They are also involved in the degradation of cell surface components and regulate multiple cellular processes, cell to cell interactions, cell proliferation, and cell signaling pathways. MMPs function in close interaction with the endogenous tissue inhibitors of matrix metalloproteinases (TIMPs), both of which regulate cell turnover, modulate various growth factors, and participate in the progression of tissue fibrosis and apoptosis. The multiple roles of MMPs and TIMPs are continuously elucidated in kidney development and repair, as well as in a number of kidney diseases. This chapter focuses on the current findings of the significance of MMPs and TIMPs in a wide range of kidney diseases, whether they result from kidney tissue changes, hemodynamic alterations, tubular epithelial cell apoptosis, inflammation, or fibrosis. In addition, the potential use of these endopeptidases as biomarkers of renal dysfunction and as targets for therapeutic interventions to attenuate kidney disease are also explored in this review.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22004677
- 003
- CZ-PrNML
- 005
- 20220127145050.0
- 007
- ta
- 008
- 220113s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/bs.acc.2021.02.003 $2 doi
- 035 __
- $a (PubMed)34809827
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Zakiyanov, Oskar $u Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic. Electronic address: oskar.zakiyanov@lf1.cuni.cz
- 245 10
- $a Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease / $c O. Zakiyanov, M. Kalousová, T. Zima, V. Tesař
- 520 9_
- $a Matrix metalloproteinases (MMPs) are a group of zinc and calcium endopeptidases which cleave extracellular matrix (ECM) proteins. They are also involved in the degradation of cell surface components and regulate multiple cellular processes, cell to cell interactions, cell proliferation, and cell signaling pathways. MMPs function in close interaction with the endogenous tissue inhibitors of matrix metalloproteinases (TIMPs), both of which regulate cell turnover, modulate various growth factors, and participate in the progression of tissue fibrosis and apoptosis. The multiple roles of MMPs and TIMPs are continuously elucidated in kidney development and repair, as well as in a number of kidney diseases. This chapter focuses on the current findings of the significance of MMPs and TIMPs in a wide range of kidney diseases, whether they result from kidney tissue changes, hemodynamic alterations, tubular epithelial cell apoptosis, inflammation, or fibrosis. In addition, the potential use of these endopeptidases as biomarkers of renal dysfunction and as targets for therapeutic interventions to attenuate kidney disease are also explored in this review.
- 650 _2
- $a extracelulární matrix - proteiny $7 D016326
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a nemoci ledvin $7 D007674
- 650 _2
- $a matrixové metaloproteinasy $x metabolismus $7 D020782
- 650 _2
- $a signální transdukce $7 D015398
- 650 12
- $a tkáňové inhibitory metaloproteinas $x metabolismus $7 D019714
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Kalousová, Marta $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Zima, Tomáš $u Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 700 1_
- $a Tesař, Vladimír $u Department of Nephrology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
- 773 0_
- $w MED00182955 $t Advances in clinical chemistry $x 2162-9471 $g Roč. 105, č. - (2021), s. 141-212
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34809827 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220113 $b ABA008
- 991 __
- $a 20220127145047 $b ABA008
- 999 __
- $a ok $b bmc $g 1751982 $s 1155826
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 105 $c - $d 141-212 $e 20210309 $i 2162-9471 $m Advances in clinical chemistry $n Adv Clin Chem $x MED00182955
- LZP __
- $a Pubmed-20220113